Navigation Links
Endo Pharmaceuticals and Orion Corporation Begin Novel R&D Collaboration
Date:1/28/2011

ive territories, and will mutually decide the most effective method to maximize product opportunities in rest of world (ROW) territories after phase II and share ROW revenues. With the establishment of the partnership Endo has exercised its option to license the lead asset in this collaboration discovered at Orion, a novel androgen-receptor antagonist for the treatment of advanced prostate cancer, which will be developed jointly by both companies for approval globally. It will be entering into phase one clinical trials in the near future.

About Orion

Orion is an innovative European R&D-based pharmaceutical and diagnostic company with a special emphasis on developing medicinal treatments and diagnostic tests for global markets. Orion develops, manufactures and markets human and veterinary pharmaceuticals, active pharmaceutical ingredients and diagnostic tests. Orion’s pharmaceutical R&D focuses on the following core therapy areas: central nervous system drugs, cancer and critical care drugs, and Easyhaler® pulmonary drugs.

The Group’s net sales in 2009 amounted to EUR 772 million. The Company invested EUR 95 million in research and development. At the end of 2009, the Group had a total of 3,100 employees, of whom 2,500 worked in Finland and 600 in other European countries. Orion’s A and B shares are listed on NASDAQ OMX Helsinki. For more information, please visit www.orion.fi/en.

Orion markets and distributes European-wide Endo’s product Vantas®.

About Endo

Endo Pharmaceuticals is a U.S.-based, specialty healthcare solutions company, focused on high-value branded products and specialty generics. Endo is redefining its position in the healthcare marketplace by anticipating and embracing the evolution of health decisions based on the need for high-quality and cost-effective care. We aim to be the premier partner to healthcare
'/>"/>

SOURCE Endo Pharmaceuticals
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related medicine technology :

1. Inovio Pharmaceuticals Closes $24.3 Million Registered Offering
2. Lotus Pharmaceuticals Provides Inner Mongolia Land Price Guidance from Cha You Qian Qi Government
3. JHP Pharmaceuticals and Putney Inc. Announce Multi-Year Contract Manufacturing Agreement
4. AVANIR Pharmaceuticals Invites Investors to Fiscal 2011 First Quarter Conference Call
5. Amylin Pharmaceuticals Reports 2010 Financial Results
6. Prolong Pharmaceuticals Leases 24,000-Square-Foot Manufacturing Facility, Adds Facilities Veteran to Executive Team
7. Savient Pharmaceuticals Names John H. Johnson Chief Executive Officer
8. Merrimack Pharmaceuticals Announces the Addition of Michael Porter to its Board of Directors
9. Optimer Pharmaceuticals Announces FDA Acceptance of NDA for Filing and Designation of Priority Review for Fidaxomicin for the Treatment of Clostridium difficile Infection (CDI)
10. CureFAKtor Pharmaceuticals Demonstrates that Novel Focal Adhesion Kinase (FAK) Inhibitors Targeted to Protein-Protein Binding Sites Inhibit Pancreatic Cancer Cells Growth
11. Amylin Pharmaceuticals to Webcast Year-End Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... , May 23, 2013  Net Medical Xpress ... telemedicine market, announced today the company has signed a ... staffing company based in Huntsville, AL ... specializes in the staffing and recruitment of telemedicine physicians. ... of the final agreement, which is expected by June ...
(Date:5/23/2013)... May 23, 2013  CAS Medical Systems, Inc. (NASDAQ: ... non-invasive patient monitoring, today announced that Thomas M. ... at the 2 nd Annual Marcum MicroCap Conference on ... New York City . The ... the Estate 10 room and will be available via a ...
(Date:5/23/2013)... NEW YORK , May 23, 2013  Intercept ... clinical stage biopharmaceutical company focused on the development and ... liver diseases, such as primary biliary cirrhosis, today announced ... and Chief Executive Officer, will present at the Deutsche ... Boston on Wednesday, May 29, 2013 ...
Breaking Medicine Technology:Net Medical Xpress Announces Acquisition of Telemedicine Staffing Company 2Net Medical Xpress Announces Acquisition of Telemedicine Staffing Company 3CASMED to Present at the 2nd Annual Marcum MicroCap Conference 2
... Calif., Sept. 23 Preclinical data of a ... blood pressure) was presented Tuesday, September 21st, at ... Washington, DC, by Christopher D. Owens, MD, MSc, ... Endovascular Surgery, University of California, San Francisco. The ...
... that a new market research report is available ... Surgical Devices: Technologies and Global Markets ... THIS REPORT CONTAINS A focus on ... devices and total disc replacement (TDR) are becoming the ...
Cached Medicine Technology:Promising New Therapy for Drug-Resistant Hypertension Presented at Interventional Cardiology Meeting in Washington, D.C. 2Reportlinker Adds Spinal Surgical Devices: Technologies and Global Markets 2Reportlinker Adds Spinal Surgical Devices: Technologies and Global Markets 3Reportlinker Adds Spinal Surgical Devices: Technologies and Global Markets 4Reportlinker Adds Spinal Surgical Devices: Technologies and Global Markets 5Reportlinker Adds Spinal Surgical Devices: Technologies and Global Markets 6Reportlinker Adds Spinal Surgical Devices: Technologies and Global Markets 7Reportlinker Adds Spinal Surgical Devices: Technologies and Global Markets 8Reportlinker Adds Spinal Surgical Devices: Technologies and Global Markets 9Reportlinker Adds Spinal Surgical Devices: Technologies and Global Markets 10Reportlinker Adds Spinal Surgical Devices: Technologies and Global Markets 11Reportlinker Adds Spinal Surgical Devices: Technologies and Global Markets 12Reportlinker Adds Spinal Surgical Devices: Technologies and Global Markets 13Reportlinker Adds Spinal Surgical Devices: Technologies and Global Markets 14
(Date:5/23/2013)... its destruction inside a cell, a cancer-promoting growth ... the development of tumor-suppressing microRNAs (miRNAs) before it,s ... at Nature . , Under conditions of ... growth factor receptor (EGFR) gums up the cell,s ... at The University of Texas MD Anderson Cancer ...
(Date:5/23/2013)... drug about to be tested in a clinical trial ... treatment for Alzheimer,s disease has failed to work with ... patients, according to results of a study by University ... of neuroscience affiliated with the Evelyn F. and William ... emphasized the importance of verifying promising research results before ...
(Date:5/23/2013)... -- Mayo Clinic researchers have used next generation genomic ... prostate cancer tumors have similar genetic origins, which may ... today in the journal Cancer Research . , ... using next generation sequencing in adjacent Gleason patterns in ... changes in pathology," says ,John Cheville, M.D., Mayo Clinic ...
(Date:5/23/2013)... "triple negative" carries a poor prognosis, with limited treatment ... cancer cells the way it,s supposed to. New research ... respond to chemotherapy, and identifies a mechanism to rectify ... Li, PhD, and his team at Western,s Schulich School ... Numb functions to promote the death of cancer cells ...
(Date:5/23/2013)... The Rottenstein Law Group LLP, a ... the Tylenol Lawsuit Information Center at http://www.rotlaw.com/tylenol , ... those who are considering filing lawsuits. , The ... severe liver damage, according to a 2009 report from ... “safety communication,” the FDA warned consumers against using more ...
Breaking Medicine News(10 mins):Health News:When oxygen is short, EGFR prevents maturation of cancer-fighting miRNAs 2Health News:When oxygen is short, EGFR prevents maturation of cancer-fighting miRNAs 3Health News:Anti-cancer drug viewed as possible Alzheimer's treatment doesn't work in UF study 2Health News:Anti-cancer drug viewed as possible Alzheimer's treatment doesn't work in UF study 3Health News:Mayo Clinic genomic analysis lends insight to prostate cancer 2Health News:Rottenstein Law Group LLP Now Accepting Tylenol Cases, Announces New Tylenol Lawsuit Information Center 2
... , TUCSON, Ariz. , ... PRSC ) today announced that Fletcher McCusker , Chairman and ... Company,s operations at the Jefferies 2010 Global Healthcare Services Conference on ... York .   , Providence,s presentation is scheduled for ...
... cheaper and more effective than existing products , WEDNESDAY, ... developed a new formula for a disinfectant that,s effective ... that cause mad cow disease. , The fast-acting disinfectant, ... it could, for instance, be used to rid surgical ...
... N.J. , Jan. 20 Which medical news stories are physicians reading to stay informed about key developments? MedPage ... Every Monday and will be available by visiting MedPageToday.com/Weekly-Top-Ten . , McNeil Expa n ... D r ug R ... z e n in ...
... ... the US marketplace in 2010. , ... Tucson, AZ (PRWEB) January 20, 2010 -- Sunquest, ... business solutions, is introducing its Integrated Clinical Environment™ (Sunquest ICE™) physician portal to ...
... ... solution. State Governments will save billions in medicaid costs, and prevent bankruptcies due to medical ... ... health care reform could bankrupt Medicaid. John Gwynne Prosser II observes California and ...
... Researchers at the University of Minnesota and Minneapolis VA ... brains of those exhibiting post-traumatic stress disorder (PTSD). ... in the study, which for the first time objectively ... magnetic fields in the brain. It,s something conventional brain ...
Cached Medicine News:Health News:Providence Service Corporation to Present at the Jefferies 2010 Global Healthcare Services Conference on Monday, January 25th 2Health News:Providence Service Corporation to Present at the Jefferies 2010 Global Healthcare Services Conference on Monday, January 25th 3Health News:MedPage Today(R) 'What Your Physicians Are Reading' 2Health News:MedPage Today(R) 'What Your Physicians Are Reading' 3Health News:Sunquest Introduces the Integrated Clinical Environment Physician Portal to US Marketplace 2Health News:Author John Gwynne Prosser II Offers "The Solution for Brain Injuries and Bankruptcies" With Free Educational Video Hosted by Google 2Health News:Researchers discover method to objectively identify PTSD 2
...
Medtronic neurosurgery external drainage and monitoring (EDM) products meet a variety of needs for CSF drainage and monitoring....
Lumbar External Drainage System (LED) with Touhy needle is indicated for temporary access to the Lumbar Subarachnoid region as a means of draining cerebral spinal fluid (CSF) in order to reduce incre...
Monitorr ICP external CSF drainage system with self-contained ICP setting....
Medicine Products: